- Home
- CHRD vs BIRK Comparison
CHRD vs BIRK Comparison
Compare CHRD & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CHRD | BIRK |
|---|---|---|
| Founded | 2007 | 1774 |
| Country | United States | United Kingdom |
| Employees | 676 | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.5B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CHRD | BIRK |
|---|---|---|
| Price | $138.49 | $41.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $149.17 | $61.43 |
| AVG Volume (30 Days) | 787.0K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.56 | $13.71 |
| Revenue Next Year | N/A | $14.30 |
| P/E Ratio | $34.53 | ★ $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.25 | $31.33 |
| 52 Week High | $151.95 | $53.53 |
Technical Indicators
Market Signals| Indicator | CHRD | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 67.50 | 40.22 |
| Support Level | $131.54 | $37.57 |
| Resistance Level | $141.72 | $42.11 |
| Average True Range (ATR) | 3.73 | 1.83 |
| MACD | 2.86 | -0.54 |
| Stochastic Oscillator | 88.96 | 6.68 |
Price Performance
Historical ComparisonAbout CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.